Uric Acid Levels and Your Genetics

What is uric acid levels?

Uric acid is the final product of purine catabolism in humans, produced in the liver and peripheral tissues when purines from dietary sources or cellular breakdown are metabolized through the xanthine oxidase pathway. Unlike most other mammals, humans cannot convert uric acid to the more soluble allantoin because the uricase enzyme became inactivated during primate evolution. As a result, uric acid circulates in the blood at concentrations close to its solubility limit, and the kidney bears primary responsibility for maintaining this balance by filtering, partially reabsorbing, and actively secreting uric acid in the proximal tubule.

Hyperuricemia — sustained elevation of serum uric acid above approximately 6.8 mg/dL — is the precondition for gout, a painful inflammatory arthritis caused by monosodium urate crystal deposition in joints. Elevated urate is also associated with uric acid kidney stones and has been studied in relation to hypertension, chronic kidney disease, and metabolic syndrome in large population datasets.

Genetics shapes where each individual's urate set-point lies on the population distribution. The 169 credible GWAS signals captured in this dataset reflect both the transporters that physically move uric acid across proximal tubule membranes and the transcription factors that orchestrate their expression in liver and kidney cells.

Research base: Robust.

The genetics behind uric acid levels

This dataset identifies 169 high-confidence genetic signals associated with serum urate, with strong causal gene prioritization at the top-ranked loci. A distinctive feature of this genetic map is the prominent appearance of hepatocyte nuclear factor genes — HNF4G and HNF1A — alongside the expected renal transporter genes. This pattern highlights how the liver and kidney co-regulate urate homeostasis through shared transcriptional programs.

SLC2A9 — GLUT9, primary urate reabsorber

SLC2A9 (rank 1, L2G 0.929) encodes GLUT9, the dominant basolateral urate reabsorber in the kidney proximal tubule. GLUT9 variants are among the strongest common genetic determinants of serum urate, with effect sizes reaching 0.5–1.0 mg/dL per allele in population studies. SLC2A9 is one of the most robustly replicated loci in urate GWAS across multiple ancestry groups, confirming the centrality of renal reabsorption to genetic urate variation.

WDR1 — WD repeat domain 1 (actin-interacting protein 1)

WDR1 (rank 2, L2G 0.946) encodes actin-interacting protein 1 (AIP1), which promotes cofilin-mediated actin filament disassembly. In kidney proximal tubule cells, dynamic actin cytoskeleton remodeling governs the apical trafficking and surface density of urate transporters. When actin dynamics are altered, the number of transporter molecules resident at the plasma membrane shifts, changing the effective transport capacity of the cell. Genetic variants in WDR1 that alter actin turnover rates can therefore influence how many urate transporter molecules are active at the tubule surface at any given time, adding a cytoskeletal regulatory layer to urate genetics.

HNF4G — Hepatocyte nuclear factor 4 gamma

HNF4G (rank 3, L2G 0.916) encodes a nuclear receptor transcription factor expressed in liver and kidney. The HNF4 family regulates a broad program controlling organic ion metabolism, including the expression of SLC22-family transporters relevant to urate handling. In the kidney, HNF4G participates in controlling the expression of proximal tubular organic anion transporter genes; in the liver, it coordinates purine catabolic gene expression and hepatic organic anion handling. Its appearance alongside HNF1A (rank 9) in the same dataset highlights the transcriptional layer of genetic control over serum urate — a layer that operates upstream of the transport proteins themselves.

PDZK1 — PDZ domain scaffolding protein

PDZK1 (rank 4, L2G 0.928) encodes a PDZ domain-containing scaffold protein that organizes organic anion transporter complexes on the apical membrane of proximal tubule cells. By tethering transporter proteins into functional membrane complexes, PDZK1 determines the effective surface expression and activity of associated urate secretion transporters. Loss of PDZK1 scaffolding reduces transporter surface expression even when the transporter proteins themselves are produced at normal levels.

DRD5 — Dopamine receptor D5

DRD5 (rank 5, L2G 0.905) encodes the dopamine D5 receptor, a G protein-coupled receptor expressed in kidney proximal tubule cells. Dopamine signaling in the kidney modulates tubular ion transport through intracellular second messenger cascades. DRD5-mediated signaling affects organic anion transporter activity and fluid reabsorption in the proximal tubule. The presence of DRD5 in this urate GWAS suggests a neuroendocrine connection to urate transport regulation — a dopamine signaling pathway that operates in the kidney independently of its central nervous system roles.

SLC10A1 — Sodium/bile acid cotransporter (NTCP)

SLC10A1 (rank 7, L2G 0.928) encodes the sodium-taurocholate cotransporting polypeptide (NTCP), primarily characterized as the hepatic uptake transporter for bile acids from portal blood into hepatocytes. NTCP is also expressed in certain tubular epithelial contexts. Its presence in the urate GWAS may reflect shared transport mechanisms for organic anions in the liver and kidney, or indirect effects on urate production through hepatic organic acid metabolism that influences the purine catabolic environment.

HNF1A — Hepatocyte nuclear factor 1 alpha

HNF1A (rank 9, L2G 0.895) is a homeodomain transcription factor that, together with HNF4G, coordinates a shared program of kidney and liver gene expression. In the kidney, HNF1A directly regulates the expression of organic anion transporters including SLC22A6, SLC22A8, and SLC22A12 (URAT1, the primary urate reabsorber). Variants in HNF1A that alter transporter expression levels can shift the efficiency of renal urate clearance without directly modifying the transport proteins themselves. HNF1A variants are also recognized in the context of monogenic diabetes (MODY3), reflecting the gene's broad role in metabolic gene regulation.

LRP2 — Low density lipoprotein receptor related protein 2 (megalin)

LRP2 (rank 11, L2G 0.891) encodes megalin, a large multiligand endocytic receptor expressed on the apical membrane of proximal tubule cells. Megalin mediates the reabsorption of a broad array of filtered proteins and small molecules from the tubular lumen, and it regulates the surface expression of co-localized membrane proteins through physical interaction. In the urate context, megalin may influence the trafficking and surface availability of transport proteins at the proximal tubule apical membrane.

What the research says about uric acid and genetics

Multiple large-scale GWAS efforts have characterized the genetic architecture of serum uric acid across diverse populations. Studies including et al. (2021); PMID 33623009 and et al. (2022); PMID 35121771 documented genetic associations at many loci, with 169 credible signals in this dataset capturing a substantial portion of the common-variant architecture. The recurring appearance of hepatocyte nuclear factor genes (HNF4G, HNF1A) alongside transporter genes (SLC2A9, PDZK1, SLC16A9) illustrates how genetic control of serum urate operates at multiple levels — from direct transport to transcriptional programs coordinating liver and kidney function.

Genetic signal summary: 169 credible GWAS signals, 168 with high-confidence causal gene prioritization. Top ranked genes: SLC2A9 (rank 1, L2G 0.929), WDR1 (rank 2, L2G 0.946), HNF4G (rank 3, L2G 0.916), PDZK1 (rank 4, L2G 0.928), DRD5 (rank 5, L2G 0.905). Evidence classification: robust, large-scale multi-cohort genetic association.

Regulatory layer coverage: Direct renal transport: SLC2A9 (reabsorption), SLC16A9 (organic anion transport). Cytoskeletal regulation of transporter trafficking: WDR1. Transcriptional coordination of transport gene expression: HNF4G and HNF1A (liver and kidney). Apical membrane scaffolding: PDZK1. Neuroendocrine tubular regulation: DRD5 (dopamine signaling). Multiligand endocytic receptor: LRP2 (megalin). Hepatic organic anion transport: SLC10A1 (NTCP).

How uric acid levels affect you

In population research, serum urate concentration is a continuous quantitative trait shaped by the cumulative effect of many genetic variants alongside dietary and lifestyle factors. Hyperuricemia — defined as serum urate chronically above approximately 6.8 mg/dL — is the point at which monosodium urate crystal formation becomes thermodynamically favorable. Gout develops when crystals precipitate in joints, triggering acute inflammatory episodes that can be severely painful. The first metatarsophalangeal joint is the most common initial site, but ankles, knees, wrists, and other joints can be affected.

Elevated serum urate is associated with uric acid kidney stones, hypertension, metabolic syndrome, and chronic kidney disease in large population cohorts. Genetic variants that increase urate production or reduce renal clearance — through the transporter and transcription factor pathways identified here — collectively shift baseline serum urate upward, increasing the statistical likelihood of crossing the hyperuricemia threshold under common dietary conditions.

This page is informational only. For health decisions, consult a qualified clinician.

Working with your uric acid profile

Serum uric acid is among the more lifestyle-modifiable metabolic biomarkers:

Purine-rich food reduction. Red meat, organ meats, shellfish, and high-purine fish (sardines, anchovies, herring) directly increase uric acid production through xanthine oxidase. Population intervention studies document 1–2 mg/dL reductions with sustained dietary changes.

Alcohol reduction, particularly beer. Beer contains purines from yeast and increases renal urate retention by elevating blood lactate, which competes with urate at renal organic anion transporters — including transporters in the SLC10A1-related hepatic organic anion pathway. Reducing beer intake is among the most impactful single dietary changes for urate management.

Fructose-containing beverage reduction. Hepatic fructose metabolism generates AMP — a purine precursor — driving upstream uric acid production. Sweetened beverage reduction reliably lowers serum urate in dietary studies and is particularly relevant given the hepatic transcription factor genetic signals (HNF4G, HNF1A) identified in this profile.

Hydration. High water intake reduces urinary urate concentration and supports renal clearance, lowering crystallization risk in both the urinary tract and joints.

Medications. Allopurinol and febuxostat (xanthine oxidase inhibitors) block production upstream; URAT1 inhibitors (lesinurad) target the same reabsorption pathway that PDZK1 scaffolds. A clinician can assess whether pharmacological urate lowering is appropriate based on clinical measurements and symptom history.

Uric acid levels connect to a broad network of renal, metabolic, and inflammatory traits:

Gout susceptibility — Chronic hyperuricemia is the necessary precursor to crystal deposition and inflammatory arthritis
Kidney stones — Uric acid stones occur when urinary pH is low and urate concentration is high; shared genetic architecture at transporter loci
Kidney function (GFR) — HNF1A and LRP2 variants connect urate genetics to broader tubular function
Metabolic syndrome and type 2 diabetes — HNF1A variants are also implicated in MODY3 (monogenic diabetes), connecting urate genetics directly to glucose metabolism regulation
Hypertension — DRD5 (dopamine signaling in kidney) connects this urate genetic profile to blood pressure regulation pathways

Genes in this genetic profile: SLC2A9, WDR1, HNF4G, PDZK1, DRD5, GPN1, SLC10A1, FAP, HNF1A, SLC16A9, LRP2, TMEM266, ABCG2.

This does not constitute a clinical evaluation, treatment recommendation, or clinical genetic test. ExomeDNA's genetic reports are for wellness and educational purposes only.

Frequently asked questions

How do transcription factors like HNF4G and HNF1A affect uric acid levels?

HNF4G and HNF1A are nuclear receptor transcription factors expressed in both liver and kidney. In the kidney, HNF1A directly regulates the expression of organic anion transporters — including URAT1 (SLC22A12), the primary urate reabsorber in the proximal tubule S1 segment. In the liver, the HNF4/HNF1 network coordinates purine catabolic gene expression and organic anion handling. Variants at these loci shift transporter expression levels, altering the efficiency of renal urate clearance without directly modifying the transport proteins themselves.

What is the role of the actin cytoskeleton in urate transport?

Renal transporters are dynamically trafficked between intracellular vesicles and the plasma membrane. The number of transporter molecules active at the cell surface — their surface expression — directly determines transport capacity. Actin filament dynamics regulate this vesicle-membrane fusion cycle. WDR1 promotes actin filament disassembly, and variants that alter its activity can shift the surface density of urate transporters, indirectly affecting how much urate the kidney secretes per unit time.

What does the dopamine receptor DRD5 have to do with uric acid?

Dopamine signaling in kidney proximal tubule cells regulates multiple transport processes through G protein-coupled receptor cascades. DRD5 activation modulates tubular organic anion handling, affecting the activity of co-expressed transporters. Genetic variants at DRD5 that alter receptor expression or signaling efficiency in proximal tubule cells may shift the balance of urate reabsorption versus secretion, contributing to individual differences in baseline serum urate.

Can genetic urate signals predict gout?

Genetic variants associated with higher serum urate increase the statistical likelihood of gout across populations — but gout is a multi-step process requiring sustained hyperuricemia, crystal nucleation, and an immune response. Many individuals with genetic urate-raising variants never develop gout, and onset is substantially influenced by diet, alcohol, body weight, and medications. A clinician can assess the combination of genetic tendency, measured serum urate, and lifestyle factors together.

Is there a difference between liver-produced and kidney-cleared urate?

Uric acid is produced primarily in the liver, where xanthine oxidase converts hypoxanthine and xanthine to uric acid. This urate is released into the bloodstream, from which the kidney filters it and regulates final excretion. The hepatic transcription factors HNF4G and HNF1A influence both the production side (purine catabolic gene expression in the liver) and the clearance side (organic anion transporter expression in kidney tubular cells), making them unique integrators of the entire urate regulatory pathway.

Browse all traits →